Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

Share Price Information for CATCo (CAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 13.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 22.00 (169.231%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 24.00
CAT Live PriceLast checked at -
CATCo Reinsurance Opportunities is an Investment Trust

To provide investors with significant capital returns and long-term distributions by making investments linked to catastrophe reinsurance risks via a variety of insurance-based investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Return of Value to Shareholders

5 Jan 2015 07:00

RNS Number : 2201B
CATCo Reinsurance Opps Fund Ltd
05 January 2015
 

 

 

 

CATCo Reinsurance Opportunities Fund Ltd. (the "Company")

 

Proposed Return of Value to Shareholders of US$0.11528 per Existing Ordinary Share, Share Capital Consolidation and Notice of Special General Meeting

 

To: SFM, London Stock Exchange and Bermuda Stock Exchange

 

 

Date: 5 January 2015

The Board is pleased to announce its intention to make a return of value to Shareholders of US$0.11528 per Existing Ordinary Share, equivalent to approximately US$35 million in aggregate (the "Return of Value"). Based on the closing middle market price of US$1.157 per Existing Ordinary Share on 31 December 2014 (being the latest practicable date prior to posting of the Circular), the proposed Return of Value to Shareholders equates to approximately 10 per cent. of the Company's market capitalisation at that date.

A Circular has today been published which provides further details of a proposal which will provide greater flexibility in how Shareholders can receive the proposed Return of Value, for which approval is being sought at the Special General Meeting to be held at 10.00 a.m. (Bermuda time) on 29 January 2015. However, if the Return of Value is not approved or does not otherwise become unconditional, the Directors intend to declare a special dividend of US$0.11528 per Existing Ordinary Share on or around 27 February 2015.

The proposed Return of Value is to be made using a B Share scheme with associated Share Capital Consolidation. This method of return has been chosen as it allows all Shareholders to be treated equally on a pro rata basis and gives the potential for Shareholders (other than Restricted Shareholders) to receive the return as either income or capital, or any combination of the two (as further described in the Circular).

The Return of Value follows the previous return of value made in January 2014, which was also executed through a B share scheme and offered Shareholders the option to receive the return as either income or capital. The Directors have chosen to preserve this option for the Return of Value, with the potential this time for Shareholders to receive their cash proceeds as a combination of both income and capital. In contrast to the previous return of value, however, Shareholders will not be offered the opportunity to remain invested for their share of the Return of Value.

Reasons for, and background to, the Return of Value

With no significant insured losses incurred on the 2014 investment portfolio the Company has concluded a successful year with the net asset value benefitting from approximately 14 cents per Ordinary Share of net insurance premiums earned over the full year.

As at 1 January 2015, the Master Fund has deployed collateralised retrocession reinsurance capacity at rates in excess of the Company's target returns. The Company's investment manager, CATCo Investment Management Ltd. (the "Investment Manager"), will provide Shareholders with an update during January 2015 regarding the 2015 portfolio.

Following the return of value that was completed in January 2014 and the share buyback programme that took place in May 2014, the Directors continue to focus on prudent capital management and ways in which Shareholder value can be optimised, whilst ensuring that the Company does nothing to constrain its growth potential.

The Directors also remain mindful of the need to maintain a disciplined investment approach with regards to risk while remaining focused on the Company's investment objective which is to target an internal rate of return in excess of LIBOR plus 12 per cent. to 15 per cent. per annum. To that end, the Directors believe that there is an optimum level of capital required to achieve these aims beyond which they may start to become impaired.

The Directors are therefore proposing to return up to approximately US$35 million by way of the proposed Return of Value, or if the Return of Value is not approved by Shareholders simply by way of a dividend.

For the avoidance of doubt, the Return of Value is separate and in addition to the annual dividend of US$0.05929 per Ordinary Share for the year to 31 December 2014 which was announced today, in line with the Company's target annual distribution of an amount equal to LIBOR plus 5 per cent. of the Net Asset Value at the end of each Fiscal Year.

The Directors, as advised by the Investment Manager and following consultation with certain Shareholders, have determined that the Return of Value is in the best interests of the Company and the Shareholders as a whole as:

· It provides Shareholders with the opportunity to realise a significant portion of the net insurance premiums earned in 2014 and to take profits in excess of the target annual distribution.

· It better enables the Company to maintain a disciplined investment approach and to target an internal rate of return in excess of LIBOR plus 12 per cent. to 15 per cent. per annum.

· It gives all Shareholders (with the exception of Restricted Shareholders) the choice as to how they receive their share of the Return of Value, which is intended to afford UK tax resident Shareholders flexibility in the tax treatment of their proceeds.

· It treats all Shareholders equally relative to the size of their existing shareholdings in the Company.

The Return of Value

The proposed Return of Value comprises a special distribution to Shareholders of US$0.11528 per Existing Ordinary Share, being approximately US$35 million in aggregate. To give Shareholders flexibility in how they receive their share of the Return of Value, it is proposed that the Return of Value is to be implemented by way of a B Share scheme under which each Shareholder will receive one B Share for every Existing Ordinary Share held at the Record Time (such entitlement being the "B Share Entitlement") and each Shareholder will be entitled to elect how the Company treats their B Shares from the two alternatives set out below (the "B Share Alternatives"). Shareholders (other than Restricted Shareholders) will be entitled to split their B Share Entitlement between the two B Share Alternatives, should they wish to do so. Accordingly, Shareholders (other than Restricted Shareholders) may elect for any combination of the B Share Alternatives, provided that the total number of B Shares in respect of which an election is made does not exceed a Shareholder's total holding of Existing Ordinary Shares as at the Record Time.

Shareholders who do not make a valid election, and all Restricted Shareholders, will be deemed to have elected for the Income Alternative in respect of all of their B Share Entitlement and will automatically receive their share of the Return of Value in cash by way of the B Share Dividend.

Shareholders should also note that the Return of Value is conditional upon the passing of Resolution 1 at the Special General Meeting.

Alternative 1 - The Capital Alternative

For B Shares validly elected to the Capital Alternative, a Shareholder will have those B Shares redeemed by the Company, free of all dealing expenses and commissions, and then cancelled. The redemption proceeds will equal US$0.11528 per B Share (with the aggregate entitlement of each holder being rounded down to the nearest cent) (the "Capital Repayment") and will be sent by cheque or credited through CREST accounts by 9 February 2015.

The amounts received under the Capital Alternative should generally be taxed as capital for UK tax purposes. UK tax resident Shareholders should read Part 7 of the Circular for further information.

Alternative 2 - The Income Alternative (B Share Dividend)

For B Shares validly elected (or deemed elected) to the Income Alternative, a Shareholder will receive a dividend of US$0.11528 per B Share (the "B Share Dividend"), which will become payable on each relevant B Share on 30 January 2015. Such dividend (with the aggregate entitlement of each holder being rounded down to the nearest cent) will be sent by cheque or credited through CREST accounts by 9 February 2015.

The amounts received under the Income Alternative should generally be taxed as income for UK tax purposes. UK tax resident Shareholders should read Part 7 of the Circular for further information.

To the extent that Shareholders validly elect for the Capital Alternative in respect of some or all of their B Share Entitlement, they will be deemed to have waived any entitlement to the B Share Dividend in respect of those B Shares that have been validly elected to the Capital Alternative.

For the avoidance of doubt, the Return of Value is separate and in addition to the annual dividend of US$0.05929 per Ordinary Share for the year to 31 December 2014 which was announced today, in line with the Company's target annual distribution of an amount equal to LIBOR plus 5 per cent. of the Net Asset Value at the end of each Fiscal Year.

The Share Capital Consolidation

The Directors believe that the Existing Ordinary Shares, like those of other closed-ended investment funds, are generally valued in the market by reference to the Net Asset Value per Ordinary Share. Accordingly, in connection with the Return of Value, the Directors are also proposing a Share Capital Consolidation, the objective of which is to seek to ensure that the Net Asset Value per Ordinary Share is the same before and after the Return of Value.

In order to effect the Share Capital Consolidation, immediately following the issue of B Shares all of the Existing Ordinary Shares will be sub-divided and consolidated into a smaller number of New Ordinary Shares, with the New Ordinary Shares having the same Net Asset Value per New Ordinary Share as the Net Asset Value per Existing Ordinary Share on 31 December 2014 as adjusted downwards to reflect the declaration of the Company's annual dividend of US$0.05929 per Ordinary Share (which was announced today with a record date of 16 January 2015, i.e. prior to the implementation of the Share Capital Consolidation).

The Net Asset Value will not be recalculated for the purposes of the Share Capital Consolidation and will be based upon the 31 December 2014 Net Asset Value adjusted as appropriate to reflect the Company's annual dividend and the Return of Value. Accordingly, the number of New Ordinary Shares to be issued in place of the Existing Ordinary Shares and hence the conversion ratio will be determined by dividing the Net Asset Value of an Existing Ordinary Share immediately following the issue of the B Shares, which will equal the 31 December Net Asset Value adjusted downwards to reflect the annual dividend and the Return of Value, by the Net Asset Value of an Existing Ordinary Share as at 31 December 2014, adjusted downwards to reflect the Company's annual dividend.

The effect of the Share Capital Consolidation will be to reduce the number of issued Ordinary Shares to reflect the overall change in the Company's Net Asset Value resulting from the Return of Value, but Shareholders will own the same proportion of the Company as they did previously, subject to fractional entitlements.

Special General Meeting

The Return of Value is conditional upon the passing of Resolution 1 and the Share Capital Consolidation is conditional upon the passing of Resolution 2 (which is also conditional on the passing of Resolution 1 and Admission), both of which will be put to Shareholders at the Special General Meeting.

The Special General Meeting will be held at Crawford House, 50 Cedar Avenue, Hamilton HM11, Bermuda at 10.00 a.m. (Bermuda time) on 29 January 2015. Notice of the Special General Meeting is set out in Part 8 of the Circular.

Recommendation

The Directors are of the opinion that the Return of Value, the Share Capital Consolidation and the Resolutions to be proposed at the Special General Meeting are in the best interests of the Company and the Shareholders as a whole. The Directors unanimously recommend that Shareholders vote in favour of the Resolutions as the Directors intend to do for their respective individual beneficial holdings of, in aggregate, 284,051 Existing Ordinary Shares, representing approximately 0.094 per cent. of the current total issued share capital of the Company.

The Board makes no recommendation to Shareholders in relation to the elections for the B Share Alternatives. Shareholders need to take their own decision in this regard and are recommended to consult their own independent professional adviser.

Unless otherwise defined, capitalised words and phrases in this announcement shall have the meaning given to them in the Circular.

Expected Timetable of Principal Events

Event Time and/or date, 2015

Latest time and date for receipt of Forms of Direction orCREST Proxy Instructions from the Depositary Interest

Holders for the Special General Meeting 10.00 a.m. (Bermuda time) on 26 January

Latest time and date for receipt of Forms of Proxy for

the Special General Meeting 10.00 a.m. (Bermuda time) on 27 January

Special General Meeting 10.00 a.m. (Bermuda time) on 29 January

Election Deadline: latest time and date for receipt of:(i) TTE Instructions from Depositary Interest Holders inrelation to the B Share Alternatives; and (ii) Forms ofElection from certificated Shareholders in relation

to the B Share Alternatives 1.00 p.m. on 29 January

Latest time and date for dealings in Existing Ordinary Shares.Existing Ordinary Share register closed and DepositaryInterests in respect of Existing Ordinary Shares disabled

in CREST 5.00 p.m. on 29 January

 

Record Time for the Share Capital Consolidation and

entitlement to B Shares 5.00 p.m. on 29 January

As soon as practicable after

B Shares issued 8.00 a.m. on 30 January

Immediately after the B Shares are issued

Share Capital Consolidation on 30 January

New Ordinary Shares admitted to trading on the Specialist Fund Market and the BSX. Dealings commence in

New Ordinary Shares 30 January

CREST accounts for Depositary Interests in respect of As soon as practicable after

New Ordinary Shares credited 8.00 a.m. on 30 January

B Share Dividend becomes payable on B Shares issued pursuant

to the Income Alternative 30 January

Redemption of B Shares 30 January

 

Outstanding B Shares on which B Share Dividend has been

paid automatically reclassified as Deferred Shares 30 January

Despatch of share certificates in respect of the New Ordinary

Shares 9 February

Despatch of cheques, or if Depositary Interests held in CREST, CREST accounts credited in respect of proceeds under the

Capital Alternative 9 February

Despatch of cheques, or if Depositary Interests held in CREST, CREST accounts credited in respect of proceeds under the

Income Alternative 9 February

 

For further information, please contact:

Judith Wynne

Company Secretary and General Counsel

CATCo Investment Management Ltd

Telephone: +44 7986 205364

Email: judith.wynne@catcoim.com

 

Mark Way

Corporate Communications Director

CATCo Investment Management Ltd

Telephone: +44 7786 116991

Email: mark.way@catcoim.com

 

David Benda / Hugh Jonathan

Numis Securities Limited

Telephone: +44 (0) 20 7260 1000

 

Copies of the following documents will be available for inspection at the registered office of the Company, Crawford House, 50 Cedar Avenue, Hamilton HM11, Bermuda during normal business hours until the conclusion of the Special General Meeting: (i) the existing Bye-laws of the Company; (ii) the new Bye-laws of the Company proposed to be adopted at the Special General Meeting, showing the amendments proposed to the Company's existing Bye-laws; and (iii) a copy of the Circular.

None of the B Shares, Deferred Shares nor the Ordinary Shares have been or will be registered under the US Securities Act or the state securities laws of the United States and none of them may be offered or sold in the United States or to any US persons unless pursuant to a transaction that has been registered under the US Securities Act and the relevant state securities laws or a transaction that is not subject to the registration requirements of the US Securities Act and the state securities laws, either due to an exemption therefrom or otherwise.

The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe such restrictions.

This announcement does not constitute, or form part of, an offer to sell or the solicitation of an offer to subscribe for any securities, nor the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issue or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEBIMFTMBAMBPA
Date   Source Headline
24th Apr 20247:00 amRNSFinal Results
23rd Feb 20247:00 amRNSNet Asset Value(s)
23rd Nov 20237:00 amRNSNet Asset Value(s)
26th Sep 20237:00 amRNSHalf-year Report
29th Aug 20237:00 amRNSNet Asset Value(s)
7th Jun 20232:00 pmRNSResult of AGM
17th May 20237:00 amRNSNet Asset Value(s)
26th Apr 20237:00 amRNSFinal Results
16th Feb 20237:00 amRNSNet Asset Value(s)
2nd Dec 20227:00 amRNSHolding(s) in Company
30th Nov 20227:00 amRNSCompulsory Acqn of Shares
21st Nov 202211:42 amRNSCompulsory Acqn of Shares - correction
21st Nov 20227:00 amRNSCompulsory Acqn of Shares
2nd Nov 20227:00 amRNSNet Asset Value(s)
11th Oct 20222:00 pmRNSPrice Monitoring Extension
14th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20227:00 amRNSNet Asset Value(s)
11th Aug 20227:00 amRNSNet Asset Value(s) and Portfolio Update
2nd Aug 202210:38 amRNSHolding(s) in Company
22nd Jul 20227:00 amRNSNet Asset Value(s)
14th Jul 20227:00 amRNSNet Asset Value Reporting Change
12th Jul 20227:00 amRNSNet Asset Value(s)
7th Jun 20227:00 amRNSNet Asset Value(s)
1st Jun 20222:00 pmRNSResult of AGM
3rd May 202212:04 pmRNSDirectorate Change
28th Apr 20227:00 amRNSFinal Results
20th Apr 20224:25 pmRNSHolding(s) in Company
19th Apr 20221:44 pmRNSHolding(s) in Company
13th Apr 20224:41 pmRNSHolding(s) in Company
13th Apr 20222:48 pmRNSHolding(s) in Company
13th Apr 20222:46 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSPartial Compulsory Redemption of Shares
29th Mar 20227:00 amRNSScheme of arrangement - Closing Date
17th Mar 20227:00 amRNSScheme of arrangement - U.S. Bankruptcy Court
11th Mar 20224:46 pmRNSScheme of arrangement - Sanction of Schemes
10th Mar 20227:00 amRNSSOA - Chairperson’s Report on Scheme Meetings
7th Mar 20227:00 amRNSNet Asset Value(s)
7th Mar 20227:00 amRNSScheme of arrangement -Sanction Hearing & Timeline
28th Feb 20227:00 amRNSScheme of arrangement - Voting deadline 1 March
24th Feb 20227:00 amRNSScheme of arrangement - US Bankruptcy Court
18th Feb 20223:04 pmRNSScheme of arrangement - Notices of Scheme Meetings
17th Feb 20227:00 amRNSScheme of arrangement - Convening Order
14th Feb 20225:31 pmRNSScheme of arrangement - Directions Hearing
11th Feb 20227:00 amRNSScheme of arrangement - Amendment of Undertakings
7th Feb 20227:00 amRNSNet Asset Value(s)
4th Feb 20227:00 amRNSScheme of arrangement - improved terms
23rd Dec 20217:00 amRNSNet Asset Value(s)
13th Dec 20212:00 pmRNSScheme of arrangement - Update
10th Dec 20217:00 amRNSScheme of arrangement - Update
18th Nov 20211:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.